GTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics (Nasdaq ...
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
Axios on MSN6h
FTC sues to block medical device coatings dealThe Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by ...
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's ...
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback